Related by context. All words. (Click for frequent words.) 80 intangible assets 69 goodwill impairment 68 intangibles impairment 68 identifiable intangible assets 67 asset impairment 67 amortization expense 66 acquired intangible assets 65 intangible impairment 64 intangible asset impairments 63 impairment charge 63 identifiable intangibles 62 amortizable intangible assets 62 intangible assets impairment 62 Harland Clarke tradename 61 amortization 61 goodwill impairment charge 61 intangibles amortization 61 impairment charges 60 amortizable 60 non recurring 59 asset impairments 58 intangible amortization 58 acquired intangibles 58 impairment 58 debt extinguishments 57 purchased intangible assets 57 unamortized deferred 57 Impairment 57 goodwill intangible 57 compensation expense 57 unallocated expenses 56 d Represents 56 Intangible assets 55 Goodwill impairment 55 unamortized debt 55 goodwill impairments 55 SunPower incurs amortization 55 nonrecurring 55 depreciable assets 54 unamortized 54 purchased intangibles 54 noncash impairment 54 Pro forma adjustments 54 Amortization 54 Non recurring 54 hedge ineffectiveness 54 unproved properties 54 pension curtailment 54 Excludes amortization 54 accrual 53 noncash impairments 53 identifiable intangible 53 FDIC indemnification 53 unrealized derivative 53 Purchased intangible assets 53 SFAS No. 53 noncash goodwill 53 f Reflects 53 leasehold improvements 53 Adjusted EBITDA excludes 53 amortized 53 Surface Specialties acquisition 53 intangibles 53 unallocated corporate 53 net realizable 53 Intangibles amortization 52 uncollectible accounts receivable 52 Adjustments Amortization 52 inventory write downs 52 incurs amortization 52 Acquired intangibles 52 realizability 52 noncash 52 marketable securities 51 CIP FENOFIBRATE 51 business acquired VOBA 51 Excludes goodwill 51 nonrecurring items 51 asset impairments restructuring 51 depreciation accretion 51 Accelerated depreciation 51 discontinued operations 51 Asset Impairment 51 inventories revalued 51 c Represents 51 unevaluated properties 51 accretion expense 51 Goodwill Impairment 51 f Represents 51 noncash goodwill impairment 51 Intangible asset 51 NETg acquisition 51 Octane Additives 51 accruals 51 LIFO adjustments 51 DAC unlock 50 Valuation allowance 50 OSIs 50 early extinguishment 50 depreciation amortization 50 asset valuation allowance 50 noncash impairment charge 50 OTTI charges 50 BioMarin Genzyme LLC 50 unamortized financing 50 unamortized portion 50 IAROC 50 Asset impairment 50 tradenames 50 LIFO adjustment 50 debt extinguishment 50 d Reflects 50 GSCT program 50 aftertax 50 unconsolidated investee 50 excluding MSRs 50 - -Labyer 50 tradename 50 SFAS 50 owned OREO 50 b Represents 50 amort 49 postretirement benefit 49 inventory obsolescence 49 Intangibles Goodwill 49 LIFO accounting 49 temporary impairments 49 Identifiable intangible assets 49 -Josephine Marcotty 49 nonrecurring expenses 49 #,#.# #,#.# Intangible assets 49 Mayne Pharma intangible assets 49 non capitalizable 49 depreciation depletion amortization 49 OTTI 49 LIFO inventory valuation 49 accumulated amortization 49 b Excludes 49 unconsolidated affiliate 49 accretion DD & 49 expensed 49 adopting SFAS #R 49 unamortized deferred financing 49 #,#,# #,#,# Impairment 49 No. #R 49 c Consists 49 FAS #R expense 49 stock basedcompensation 49 intangible impairments 49 Acquired Intangible Assets 49 early extinguishments 49 c Includes 49 nonoperating expense 49 unamortized discount 49 Excluding goodwill impairment 49 Addback Depreciation 49 Unallocated expenses 49 valuation allowances 49 c Reflects 49 Contingent consideration 48 amortized cost 48 OREO properties 48 OTTI charge 48 Pro forma adjusted EBITDA 48 QSI segment certain 48 accelerated depreciation 48 Alcott Routon intangible assets 48 depreciation amortization impairment 48 unamortized issuance costs 48 Restructuring asset impairments 48 Equity Investees 48 Partnered Brands segment 48 valuation adjustments 48 SurfControl deferred revenue 48 lease terminations 48 noncurrent assets 48 pretax goodwill impairment 48 Pro forma EBITDA 48 excluding depreciation depletion 48 MFB Corp 48 Filtran Microcircuits Inc. 48 depletion depreciation 48 adjusted EBITDAR 48 preopening expenses 48 undepreciated 48 noncash intangible 48 aftertax charge 48 Noncash 48 Oxy ER 48 intersegment eliminations 48 Consolidated Adjusted EBITDA 48 - Adjusted [025] 48 postretirement benefits 48 OREO valuation 48 temporary impairments OTTI 48 Equinix excludes 48 excludes depreciation amortization 48 Impairments 48 NOL carryforwards 48 Qualcomm Strategic Initiatives 48 b Includes 48 excludes amortization 48 - Adjusted [006] 48 FAS CAS pension 48 depreciable asset 47 Identified intangible assets 47 FDIC indemnification asset 47 depreciable real estate 47 undiscounted cash 47 capitalizable 47 taxes EBDDT 47 equity investee 47 operatingincome 47 carryforwards 47 valuation allowance 47 c Excludes 47 warranty accruals 47 3Q FY# 47 Xantic acquisition 47 Non GAAP adjusted EBITDA 47 LIFO inventory 47 Impairment Charges 47 Asset impairments 47 Pro forma net 47 AGY Asia 47 amortization EBIDTA 47 Amortisation 47 INOVA Geophysical 47 amortization #,#,# 47 receivable balances 47 unrealized gain 47 Fine Chemicals segment 47 Other Intangible Assets 47 Purchased intangibles 47 unabsorbed fixed manufacturing 47 - Adjusted [019] 47 OREO 47 amortize intangible assets 47 temporary impairment OTTI 47 realizable value 47 pretax noncash charges 47 netincome 47 Accretion expense 47 Intangibles net 47 Adjusted OIBDA excludes 47 Pro forma EPS 47 DAC offsets 47 reasonably estimable 47 noncash amortization 47 depreciation amortization accretion 47 Polo Jeans Company 47 Nitram backlog 47 Thomas Regout operations 47 intercompany balances 47 charterhire 47 accounts receivable balances 47 #,#,# #,#,# Amortization 47 SFAS No.# 47 Clarica brand 46 QUALCOMM Strategic Initiatives 46 Real Estate Owned OREO 46 - Operating [026] 46 Tecstar Automotive Group 46 unamortized balances 46 MAGNETIX 46 PGP Acquisition 46 Purchased Intangible Assets 46 Excludes depreciation 46 postemployment benefits 46 Capital expenditures 46 amortization# 46 - Adjusted [012] 46 unconsolidated joint 46 unfavorable variance 46 Visa indemnification 46 FAS #R 46 Adjusted diluted 46 continuingoperations 46 unrealized gains 46 - Adjusted [024] 46 Intangible amortization 46 EBIAT 46 Neurobionix 46 Intangible amortization expense 46 Other Income Expense 46 - Non GAAP [002] 46 derivative liabilities 46 deposit intangible 46 Asset Retirement Obligation 46 Adjusted EBITDAX 46 pretax noncash 46 LAE reserves 46 fiscal# 46 Timeshare segment 46 nonroutine income 46 Operating Expenses 46 Goodwill #,#.# #,#.# 46 -Angelo Nieves 46 -Ivgi 46 IPRD 46 Dropdown Predecessor 46 doubtful accounts receivable 46 Diluted EPS attributable 46 unrealized hedging 46 -killing Alan Shalleck 46 Amortization Expense 46 Depletion depreciation amortization 46 FAFLIC 46 - Non GAAP [019] 46 items affecting comparability 46 FASB Statement #R 46 - Adjusted [028] 46 #.#per diluted 46 YTD Fiscal 46 Amortized 46 OTHER ASSETS Goodwill 46 Unallocated corporate 46 depreciation amortization depletion 46 unconsolidated subsidiaries 46 DYNEPO 46 - Adjusted [033] 46 exclude noncash 45 TWACS NG software 45 excluding goodwill impairment 45 SFAS #R 45 pro forma adjusted EBITDA 45 OxyVinyls 45 Intangible 45 Normalized EBITDA 45 g Represents 45 aftertax gain 45 Unizan merger 45 - Adjusted [026] 45 nonoperating expenses 45 FAS CAS Pension 45 obsolete inventory 45 Unusual Items 45 Goodwill impairment charge 45 accretable 45 CTVgm 45 b Relates 45 loss NOL carryforward 45 DiaMed acquisition 45 Pigments segment 45 Intangible Assets 45 ended September# 45 receivable 45 noncash accounting 45 Non GAAP net 45 unrealized appreciation 45 Nonrecurring 45 unabsorbed manufacturing 45 -orchitis 45 PLAVIX R 45 Goodwill #,#,# #,#,# [002] 45 #.#/diluted share 45 noncash pretax 45 estimated undiscounted 45 per dilutedshare 45 postretirement 45 Lilly ICOS joint venture 45 Derivative Liabilities 45 excluding depreciation amortization 45 diluted share 45 Purchased Intangibles 45 Operating Income 45 Intangibles 45 Tax Expense 45 - Adjusted [009] 45 equity accounted investees 45 nonoperating income 45 Oilseeds Processing 45 Adjusted EBIT 45 THALOMID 45 goodwill amortization 45 derivative instruments 45 ABELCET 45 Hedge ineffectiveness 45 Non GAAP Diluted EPS 45 Depreciation Amortization 45 NOL utilization 45 - INVESTING ACTIVITIES [004] 45 severance accruals 45 Restricted Cash 45 ScissorTail 45 - -OfficeMax ImPress R 45 Intangible Assets Net 45 - Non GAAP [015] 45 Adjusted 45 DOVONEX 45 EUR -#.# [001] 45 Amortizable intangible assets 45 undernoted items 45 Goodwill impairment - [002] 45 - - [124] 45 infrequently occurring 45 #,#.# #,#.# Goodwill [002] 45 noncash charge 45 b Reflects 45 Symphony GenIsis 45 intangible assets imputed 45 consolidated balance sheet 45 undesignated hedges 45 NOTE Facet Biotech 45 Tradename 45 Copano commodity 45 administrative expenses 45 - Adjusted [016] 45 Novogyne 45 Visa MasterCard antitrust 45 - - Net [047] 45 LIFO reserve 45 nine monthsended 45 adjusted EBITDAS 45 ofapproximately 45 intercompany eliminations 45 Interest expense 45 amortize goodwill 45 remeasurement 45 Inventory writedown 45 EUR#.#million 45 FSP #-# 45 noncurrent liabilities 45 -BY LESLIE BIXLER • 45 depreciable 45 accrual reversal 45 deferred loan origination 45 FASB Interpretation No. 45 Unallocated Corporate 45 - Adjusted [022] 44 Armkel 44 mandatorily redeemable 44 unrealized losses 44 - Adjusted [010] 44 postretirement benefit plans 44 #.# perdiluted 44 PMPS brand 44 invoiced shipments 44 depreciation 44 -Duncalfe 44 -Brad Dorfman editing 44 postretirement expense 44 Filtran 44 Lease termination 44 OPERATING LOSS INCOME 44 - Operating [028] 44 pretax 44 - - [019] 44 Concateno plc 44 - Adjusted [007] 44 #,#,# #,#,# Goodwill [002] 44 unrealized derivative gain 44 Brooks Eckerd acquisition 44 Facet Biotech logo 44 Harland Acquisition 44 MDS Proteomics 44 - Adjusted [017] 44 - - [092] 44 Compensation Expenses 44 DJO Merger 44 expenses LOE 44 - Non GAAP [012] 44 - - [103] 44 DAC unlocking 44 Acquisitions dispositions 44 Panbio Limited 44 Purchased intangibles net 44 - Non GAAP [018] 44 BioGlue ® 44 Olefins Polyolefins 44 FASB #R 44 Adjusted Gross Profit 44 Cobalt Gordian 44 Adjustments Impairment 44 Endoscopic Technologies 44 - Operating [019] 44 Brooks Eckerd drugstore chain 44 Accounts receivables 44 Iceland Latvia Lithuania 44 Therics 44 - - Total [007] 44 specialized polyolefin plastic 44 - Non GAAP [023] 44 EBDDT 44 SEK -#.# -#.# [003] 44 - Operating [009] 44 NA HME 44 Significant Items 44 QSI segment 44 c Relates 44 Essentis 44 Capitalized software 44 Drivetrain segment 44 GS FLX TITANIUM 44 FSP FAS #-# 44 Debt extinguishment costs 44 -ounce Soy Deli 44 invoiced shipment 44 Lasertel subsidiary 44 Impairment Losses 44 non amortizing intangible 44 earnouts 44 flow hedges 44 goodwill 44 ascompared 44 excluding nonrecurring 44 assets1 44 Normalised earnings 44 excluding BIBP 44 Assets Quality Ratios 44 SchoolHouse division 44 discount accretion 44 Adjusted EBITDA 44 prioryear 44 ACTIVITIES Acquisition 44 ceded reinsurance 44 Administrative Expenses 44 Panamax Bulk Carrier 44 research anddevelopment 44 intercompany transactions 44 Non Current Assets 44 Note Receivable 44 - Adjusted EBITDA [006] 44 #,# -Outasight 44 TACLONEX 44 Impairment Charge 44 EUR -#.# -#.# [001] 44 ONTAK 44 earnout payment 44 Non GAAP adjustments 44 Mircette R 44 non gaap 44 -Gottron 44 net# [002] 44 Lubrizol Additives segment 44 commodity derivative instruments 44 Milestone Payments 44 Fuwan Silver 44 Re eng 44 Intangible assets net 44 MSRs 44 2Q FY# [001] 44 incentive accruals 44 capital expenditures 44 Pro forma 44 equity method investees 44 - - Non GAAP [008] 44 loss carryforwards 43 Writedown 43 Consolidated OIBDA 43 AMPAC ISP Holdings 43 - - Total [037] 43 Tikcro holdings 43 Och Ziff Operating 43 -Brookfield Asset Management BAMa.TO 43 MA PFFS 43 Excludes 43 Astaris joint venture 43 #,# -oxidative enzymes 43 - Adjusted [030] 43 GAAP 43 Amortiza tion 43 unrealized depreciation 43 #.#/BOE [001] 43 unrealized derivative gains 43 -TUMS 43 expenses# [002] 43 Humibid 43 SATIATRIM 43 amortization DD 43 Interest expense decreased 43 leaseback transactions 43 No. #R SFAS 43 Avantome Inc. 43 Operating expenses 43 Pro Forma EBITDA 43 NOI decreased 43 - Non GAAP [003] 43 Items excluded 43 liabilities 43 Restructuring Charges 43 share excluding AOCI 43 - Total assets [003] 43 Goodwill Impairment Charge 43 PTOI 43 -blueberry barrens 43 Teveten 43 unamortised 43 leaseback transaction 43 Restructuring 43 Unamortized 43 recourse indebtedness 43 accounts receivable 43 - - Earnunderwent resection 43 Reconciling Items 43 divestitures 43 Mortgage Servicing Rights 43 AcG 43 j Includes 43 timberland disposals net 43 Expensed 43 Order Backlog 43 Amorti zation 43 Additions Accrual Basis 43 Acquired Assets 43 LIFO provision 43 n#.# [002] 43 - Operating [004] 43 SigmaKalon acquisition 43 - - Non GAAP [007] 43 Restructuring Charge 43 standardized distributable cash 43 non CDFS 43 non cancelable lease 43 #compared 43 operating income1 43 Discontinued Operations 43 excludes depreciation 43 DPAC amortization 43 PGS Onshore acquisition 43 ASC #-#-# 43 Pharmacia Monsanto 43 Gross Addition CPGA 43 amortizing 43 Azactam 43 Acquiree 43 FIFO inventory 43 Corus Aluminum 43 earnings pershare 43 LPT Agreement 43 ABILIFY R 43 Than Temporary Impairment 43 shutdowns asset impairments 43 ColepCCL 43 Atria Genetics 43 adopting SFAS 43 assets# [002] 43 Restructuring Expenses 43 LIFO inventory reserve 43 - Non GAAP [021] 43 - NET CASH [004] 43 exchangeable debentures 43 Adjusted Earnings 43 Curtailment gain 43 3Q FY# representing 43 FAS# R 43 1Q FY# representing 43 unamortized premiums 43 - Operating [029] 43 noninterest expense decreased 43 noninterest expense 43 - - Income [022] 43 EBITDA EBITDAM EBITDAR 43 Silvue 43 undepreciated assets 43 PRAVACHOL R 43 Specialty Chemicals segment 43 Loss Gain 43 - AdjusETON 43 Maxipime 43 Interest Income Expense 43 MSR hedging 43 Long Lived Assets 43 #,#,# #,#,# - [013] 43 4Q FY# 43 Based Compensation 43 incur unanticipated 43 Other Specified Items 43 Privileged Access 43 EBITD 43 Contingent Consideration 43 unfavorably impacted 43 DNOI 43 Titanium Dioxide Pigments 43 nonGAAP 43 Investing Activities Purchase 43 Total noninterest expense 43 Surface Specialties 43 Offerors Commercial applies 43 - Loss [010] 43 Asset Impairment Charge 43 - Non GAAP [009] 43 JPY2 43 pro forma EBITDA 43 Arana Therapeutics Limited 43 BlackRock MLIM transaction 43 c Calculated 43 #,#,# Accumulated depreciation 43 Deductions depreciation 43 Writeoff 43 amorti zation 43 -Juan'ya Green 43 barrels MMBbls 43 PANZYTRAT 43 Excluding 43 Unusual Items section 43 SG &A; 43 nonoperating 43 - - [122] 43 Dynepo TM 43 EBITDAO 43 Min Kum 43 #R Share Based 43 mandatorily redeemable preferred 43 Wellbutrin XL R 43 ASC #-# 43 SEK -#.# [002] 43 intercompany 43 - Loss [033] 43 OREO write downs 43 JPY3 43 TOTAL EXPENSES 43 Represents 43 - Adjusted [014] 43 Ps.3 43 Nonoperating income 43 currency translation 43 - Operating [015] 43 Excluding nonrecurring items 42 AZASITE 42 unconsolidated entities 42 - Non GAAP [027] 42 Consolidated EBITDAR 42 - Adjusted EBITDA [001] 42 Omnicef inventory 42 -lipid nanoparticles 42 Total Assets 42 Interest expense net 42 Accounting Guideline AcG 42 translation adjustment 42 intercompany loans 42 MSR valuation 42 Commercial Laminating Solutions 42 Business Combinations 42 Segment Profit 42 CIC convertible debenture 42 - Adjusted [005] 42 Legerity acquisition 42 depletable base 42 Nonrecurring items 42 Derivative instruments 42 Modified EBITDA 42 nonvested stock 42 Snowbush Microelectronics 42 undrawn revolver 42 equity investees 42 LOGIX SA 42 #.#/BOE [002] 42 FSP APB #-# 42 unaccreted 42 deferred 42 WWS Divestiture 42 favorably impacted 42 SORL consolidated 42 Hwada 42 cash equivalents marketable securities 42 intersegment revenues 42 Capitalized 42 - SegmentPrincess Dina Mired 42 Non GAAP Adjusted EBITDA 42 Core FFO 42 Debt extinguishment 42 Discontinued operations 42 Goods Sold 42 BioOne Corporation 42 GBP #.#m [003] 42 notes receivable 42 - - Net [003] 42 Restructuring impairment 42 Acquired intangible assets 42 - - [035] 42 Asset Retirement Obligations 42 millioncompared 42 -Tilak Marg 42 Ruili Group 42 SFSB transaction 42 - Adjusted [020] 42 #,#,#,# [010] 42 Contingent Value Right 42 Futureway Communications Inc. 42 - - [094] 42 Fumapharm AG 42 NATRECOR 42 EITF #-# [001] 42 Non Recurring 42 RMB#.# [008] 42 Adjusted FFO 42 Depreciation amortization 42 contractual minimums 42 redeemable noncontrolling interest 42 Symphony Icon 42 Depreciation depletion amortization 42 Geno Excellent 42 Administrative SG 42 #,# -BOB SANSEVERE 42 Vancocin R 42 Reclassifications 42 Noninterest expenses 42 - OperatiMcGrath RentCorp 42 BOLI COLI 42 DARA logo 42 Excluding nonrecurring 42 noncash writedown 42 mark eOn 42 currency remeasurement 42 ZBx 42 Adjusted OIBDA 42 Revance 42 convertible subordinated notes 42 STRIANT 42 Noncurrent assets 42 - Adjusted [008] 42 TSX BLD NASDAQ BLDP 42 Variable Interest Entities VIEs 42 reportable segment 42 VISaer 42 Adjustments Restructuring 42 intersegment transactions 42 Huipu 42 SOLODYN R 42 successfully integrate Legerity 42 undernoted 42 contingently convertible securities 42 taxes depreciation amortization 42 ELND# AZD 42 unrealized 42 Specified Items 42 unbooked resource potential 42 Leveraged Lease 42 Segment EBIT 42 Solectron pro forma 42 DKK #m 42 non GAAP 42 SWDCC 42 Less Accumulated depreciation 42 = ReconciliIsilon IQ delivers 42 securitized receivables 42 -triseries 42 Adjusted Operating Expenses 42 primarily attributable 42 Operating Expenses Operating 42 accounts receivable securitization 42 Non GAAP 42 Goodwill #,#,# #,#,# [001] 42 impacting comparability 42 Transferred Assets 42 - Revenues [006] 42 earnout payments 42 reinsurance recoverables 42 Unfavourable Changes 42 Consolidated adjusted EBITDA 42 - - [021] 42 Z5 Technologies 42 Domestic Car Rental 42 - - [015] 42 #,#,# #,#,# Depreciation 42 Unlevered Cash Flow 42 #,# -Radhika Menon Theodore 42 Vinyls segment 42 Nonperforming assets totaled 42 intercompany receivables 42 Smart Shirts 42 SPECIAL ITEMS 42 amorti 42 Merger Related 42 - - Total [072] 42 Other assets# [001] 42 Intangible Amortization 42 SCNI 42 marketable securities totaled 42 Mylan Bertek 42 -Laemmle Music 42 SFAS# 42 Solidifies Leadership 42 Eur #,# 42 Stendal mill 42 Intangible assets amortization 42 - #,#.# #,#.# [002] 42 NASDAQ CRTX 42 depreciation depletion 42 Non NAREIT Compliant 42 Adjusted EBT 42 AMF Ultra Short 42 Polymer Additives segment 42 modified coinsurance 42 Movado boutiques 42 Cardium Therapeutics TM 42 x Immtech 42 MDP Transaction 42 MSEK -# [001] 42 OPANA ER 42 - Total operating 42 - - Total [056] 42 Related Costs 42 amoritization 42 profitsharing 42 unrealized gains losses 42 noncontrolling interest 42 Ps.#.# [007] 42 minimally dilutive 42 postretirement benefit expense 42 BEFORE TAXES 42 - - Nesignandsight newsletter 42 - NeDEFENDERS 42 nonsedating antihistamine 42 Needle Roller Bearings 42 Ultane Sevorane 42 Pretax 42 Domilens 42 - - Net [031] 42 Megace R ES 42 FAS# [001] 42 Protana 42 Depreciations 42 Nonutility 42 ASC Topic 42 Wellbutrin XL ® 42 TM Acetavance TM 42 #,# -Preachintothedevil 42 PLAVIX ® 42 Buzzard derivative 42 Discretionary cash 42 #,#,# #,#,# TOTAL ASSETS [002] 42 Acquired Intangibles 42 reimbursable expenses 42 Vyvx advertising 42 PENTASA 42 - - [111] 42 Alasko c o 42 Doubtful Accounts 42 Depreciation 42 Becomes Wholly Owned Subsidiary 42 Items impacting comparability 42 Based Compensation Expense 42 -#,# -#,# [002] 42 repossessed assets 42 Kauko Telko 42 Naglazyme R 42 Hypernex assets 42 accumulated depreciation 42 = Loss [007] 42 goodwill writedown 42 - - Net [040] 42 Adjusted EBITDAR 42 receivables 42 viii insufficient 41 USGAAP 41 Partially offset 41 Fab 3E 41 Scantron segments 41 Purchased intangibles amortization 41 Onco TCS 41 - - [023] 41 Depletion Depreciation 41 - Operating [030] 41 -cleveland.com 41 OIBA 41 undiscounted 41 Folgers R 41 non recourse RISPERDAL 41 postretirement benefit obligations 41 Amortiz 41 - Operating [001] 41 Noninterest 41 include ClindaReach TM 41 Aldara ® 41 Deposit Intangible 41 Investing Activities Acquisitions 41 FINANCIAL DETAILS 41 sale leaseback transaction 41 - Net [006] 41 Normalized FFO 41 Petrojarl Varg FPSO 41 Acquired intangible asset 41 EURO#.# [002] 41 Cerner logo 41 ceding commissions 41 PentaStaph 41 Noninterest expense decreased 41 ZALBIN ™ 41 affecting comparability 41 Recurring EBITDA 41 FASB Statement 41 Pandel R 41 partially offset 41 uncollectible accounts 41 Reported Unaudited Condensed 41 - Diluted 41 REVENUES Revenues 41 thecompletion 41 Intangible assets Goodwill 41 - #,#,# #,#,# [006] 41 - - NetMarigot Bay r 41 Expenses incurred 41 ChannelRe 41 PDL BioPharma logo 41 - Loss [020] 41 INVESTING ACTIVITIES Purchase 41 Related Expenses